Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the Netherlands
Metabolic response on [¹⁸F]FDG-PET/CT, particularly CMR, strongly correlates with pathological response after neoadjuvant pembrolizumab. ILN response accurately reflects total nodal basin response, supporting response-adapted surgical strategies.
Institutions
- Erasmus MC (NL)
- The Netherlands Cancer Institute (NL)
- Oncode Institute (NL)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1016/j.ejca.2026.116691
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00